2.94
+0.34%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Apyx Medical
From its filings with the US Securities and Exchange Commission
Apyx Medical is based in Clearwater, Florida and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker APYX. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $52.8m and a net loss of $11.2m. At that date it held total assets of $66.8m and shareholders' equity of $14.5m. By region, UNITED STATES accounted for 73.4%, followed by Non-US [Member] at 26.6%.
Apyx Medical Corporation (“Company”, “Apyx Medical”, “we”, “us”, or “our”) was incorporated in 1982, under the laws of the State of Delaware and has its principal executive office at 5115 Ulmerton Road, Clearwater, FL 33760.
We are a surgical aesthetics company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® and the AYON Body Contouring SystemTM (“AYON”) in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. AYON is an FDA-cleared, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, and Renuvion’s tissue contraction and electrosurgical capabilities, empowering surgeons to deliver comprehensive body contouring treatments for patients. We also leverage our deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.
Quoted from its 10-K, filed 10 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 22 Jul 1983
- Employees
- 205
- Website
- apyxmedical.com ↗
- Head office
- 5115 ULMERTON ROAD, CLEARWATER, FL, 33760
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Stavros VizirgianakisIndependent Chairman of the Board$40,697
- Mr. Charles GoodwinPresident, Chief Executive Officer, Director, since 2017$975,971
- Mr. Matthew HillChief Financial Officer, Treasurer, Secretary$780,234
- Mr. Shawn RomanChief Operating Officer$425,594
- Mr. Moshe CitronowiczSenior Vice President$483,478
- Mr. Lawrence WaldmanLead Independent Director$113,331
- Ms. Minnie Baylor-HenryIndependent Director$65,456
- Ms. Wendy LevineIndependent Director$53,581
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 44
- Environment
- 16
- Social
- 34
- Governance
- 81
- Women in the workforce
- 52%
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Apyx Medical Corp has several strengths that contribute to its success in the medical technology industry.
Weaknesses
- Despite its strengths, Apyx Medical Corp also faces certain weaknesses that need to be addressed.
Opportunities
- Apyx Medical Corp can leverage various opportunities to further expand its market presence and profitability.
Threats
- Apyx Medical Corp should also be aware of potential threats that could impact its operations and market position.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.